Why the study?
Does home hemodialysis improve patient and technique survival compared to CAPD in nondiabetic patients with end-stage renal disease?
Population
278 nondiabetic patients with end-stage renal disease starting home dialysis
Comparison
Home hemodialysis vs Continuous ambulatory peritoneal dialysis (CAPD)
Design
Cohort
Follow-up
3 years
Authors
Loading...
Home HD was associated with superior 3-year survival versus CAPD; leaves open whether selection bias drives the observational difference.
Does home hemodialysis improve patient and technique survival compared to CAPD in nondiabetic patients with end-stage renal disease?
Home hemodialysis is associated with superior patient and technique survival at 3 years compared to CAPD, though this may be partly driven by selection bias.
Grant et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: